Published in Int J Qual Health Care on October 01, 1996
Involvement of consumers in the development of evidence based clinical guidelines: practical experiences from the North of England evidence based guideline development programme. Qual Health Care (2001) 2.70
Development of guidelines to facilitate improved support of South Asian carers by primary health care teams. Qual Health Care (2001) 1.72
Reconsidering patient participation in guideline development. Health Care Anal (2008) 1.47
Are guidelines ethical? Some considerations for general practice. Br J Gen Pract (2002) 1.30
How to integrate individual patient values and preferences in clinical practice guidelines? A research protocol. Implement Sci (2010) 1.24
Feasibility of a wiki as a participatory tool for patients in clinical guideline development. J Med Internet Res (2012) 1.14
An empirical study of patient participation in guideline development: exploring the potential for articulating patient knowledge in evidence-based epistemic settings. Health Expect (2013) 0.93
Consumer involvement in topic and outcome selection in the development of clinical practice guidelines. Health Expect (2011) 0.91
Shared decision making does not influence physicians against clinical practice guidelines. PLoS One (2013) 0.83
Collaborating with consumer and community representatives in health and medical research in Australia: results from an evaluation. Health Res Policy Syst (2011) 0.80
Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol (2001) 3.87
What are the effects of the fifth revision of the Declaration of Helsinki? BMJ (2001) 3.17
Sociocultural issues in clinical research. Arthritis Rheum (2001) 2.71
Australia's consumer champion. BMJ (1999) 2.09
[Management of pregnant women infected with HIV at Bichat Hospital between 1990 and 1998: analysis of 202 pregnancies]. Gynecol Obstet Fertil (2001) 2.05
Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor? Arthritis Rheum (2011) 2.01
Speaking up for ourselves. The evolution of consumer advocacy in health care. Int J Technol Assess Health Care (1998) 1.54
Confined, managed and delivered: the language of obstetrics. Br J Obstet Gynaecol (1992) 1.38
HIV-1 detection in cervicovaginal secretions during pregnancy. AIDS (1997) 1.01
[Winter supplementation in the 3rd trimester of pregnancy by a dose of 80,000 IU of vitamin D]. J Gynecol Obstet Biol Reprod (Paris) (2001) 0.94
Regulation of the expression of the phosphoenolpyruvate carboxykinase gene in cultured rat hepatocytes by glucagon and insulin. Eur J Biochem (1988) 0.90
Allies or enemies? Evidence-based medicine and consumer choice. Med J Aust (2000) 0.84
Competing or complementary? Ethical considerations and the quality of randomized trials. Int J Technol Assess Health Care (1996) 0.84
Modulation by oxygen of the glucagon-dependent activation of the phosphoenolpyruvate carboxykinase gene in rat hepatocyte cultures. Eur J Biochem (1991) 0.83
[The development of health information with the involvement of consumers at the German Institute for Quality and Efficiency in Health Care (IQWiG)]. Gesundheitswesen (2010) 0.81
Detection of acrolein congener-DNA adducts isolated from cellular systems. Arch Toxicol Suppl (1989) 0.80
Molecular mechanisms of DNA damage initiated by alpha, beta-unsaturated carbonyl compounds as criteria for genotoxicity and mutagenicity. Environ Health Perspect (1990) 0.77
[Effects of electrostimulation (Veinoplus) on lower limbs venous insufficiency-related symptoms during pregnancy. Preliminary study]. Gynecol Obstet Fertil (2008) 0.76
Commentary: "health has become secondary to a sexually attractive body". BMJ (1999) 0.75
[Results of surgical treatment of syndactylia of the hand]. Beitr Orthop Traumatol (1989) 0.75
[Update of early arthritis and early rheumatoid arthritis]. Dtsch Med Wochenschr (2005) 0.75
Personal beliefs and alternative childbirth choices: a survey of 552 women who planned to give birth at home. Birth (1993) 0.75
[New biologics and orally available compounds. What is still in the pipeline?]. Z Rheumatol (2010) 0.75
[Results following endoprosthetic management of traumatically damaged finger joints]. Beitr Orthop Traumatol (1987) 0.75
Obstetrics and litigation: a consumer perspective. Med J Aust (1990) 0.75
Has involving consumers (patients) in research made any difference to what is researched and how? J Health Serv Res Policy (1999) 0.75
[Tasks in physical therapy following hand surgery]. Krankenpfl J (1992) 0.75
DNA adducts of allyl compounds, enals and unsaturated ketones. Significance for mutagenicity and carcinogenicity. IARC Sci Publ (1994) 0.75